Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase

Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase

US Patent 9724354 · Granted Aug 8, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer treatment methods based on TP53 mutation status and hypermutation2024
Methods of treating gastrointestinal immune-related adverse events in immune onc2023
Antibodies specific for DR5 and methods of use2022
Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for thei2019
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR52018
Cell penetrating peptides to target EIF4E2016